{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-062595","form_type":"8-K","ticker":"BCLI","cik":"0001137883","company_name":"BRAINSTORM CELL THERAPEUTICS INC.","filed_at":"2025-06-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.632354+00:00","generated_at":"2026-05-18T18:59:29.945079+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Brainstorm Cell shareholders approve 2M share increase in equity plan pool","bullets":["Shareholders approved increasing the shared pool under the 2014 plans by 2M shares, to 2,906,666 shares.","Vote: 758,668 for, 362,809 against, 2,556,446 broker non-votes for the plan amendments.","All seven director nominees elected; Dr. Stacy Lindborg received the most votes (1,055,967 for).","Ratification of Brightman Almagor Zohar & Co. as FY2025 auditor approved (3,346,891 for).","Approval of warrant share issuance under Nasdaq Rule 5635(d) passed (874,965 for)."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-062595","json":"https://secwatch.observer/filing/0001104659-25-062595.json","markdown":"https://secwatch.observer/filing/0001104659-25-062595.md","text":"https://secwatch.observer/filing/0001104659-25-062595.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1137883/000110465925062595/0001104659-25-062595-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1137883/000110465925062595/tm2518995d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T18:59:29.945079+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}